Novel aspects of orbital fibroblast pathology

Journal of Endocrinological Investigation

Volumn 27, Issue 3, 2004, Pages 246-253

  Smith, Terry J ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemokines; Graves' disease; IGF I receptor; Self antigen

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CYTOKINE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; IMMUNOGLOBULIN G; INTERLEUKIN 16; INTERLEUKIN 1BETA; INTERLEUKIN 8; PROSTAGLANDIN E2; RANTES; SOMATOMEDIN C RECEPTOR;

ANTIGEN BINDING; CONNECTIVE TISSUE; ENDOCRINE OPHTHALMOPATHY; FIBROBLAST; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; INFLAMMATORY INFILTRATE; MEDIATOR RELEASE; NONHUMAN; PATHOGENESIS; PATHOLOGY; PHENOTYPE; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 2342454336     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345273     Document Type: Review

References (46)

1. Noden DM. Periocular mesenchyme: neural crest and mesodermal interactions. In: Jakobiec FA ed. Ocular anatomy, embryology and teratology. vol. 97. Philadelphia: Harper and Row. 1982, 119.
2. Anderson DJ. Molecular control of cell fate in the neural crest: the sympathoadrenal lineage. Annu Rev Neurosci 1993, 16: 129-58.
3. Smith TJ, Bahn RS, Gorman CA. Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: evidence for differences between retroocular and dermal fibroblasts. J Clin Endocrinol Metab 1989, 69: 1019-23.
4. Henrikson RC, Smith TJ. Ultrastructure of cultured human orbital fibroblasts. Cell tissues Res 1994, 278: 629-31.
5. Smith TJ, Kottke RJ, Lum H, Andersen TT. Human orbital fibroblasts in culture bind and respond to endothelin. 1993, 265:C138-42.
6. Beresenson CS, Smith TJ. Human orbital fibroblasts in culture express ganglioside profiles distinct from those in dermal fibroblasts. J Clin Endocrinol Metab 1995, 80: 2668-74.
7. Smith TJ, Bahn RS, Gorman CA, Cheavens M. Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblasts. J Clin Endocrinol Metab 1991, 72: 1169-71.
8. Smith TJ, Wang HS, Evans CH. Leukoregulin is a potent inducer of hyaluronan synthesis in cultured orbital fibroblasts. Am J Physiol 1995, 268:C382-8.
9. Young DA, Evans CH, Smith TJ. Leukoregulin induction of protein expression in human orbital fibroblasts: Evidence for anatomical-site-restricted cytokine-target cell interactions. Proc Nat Acad Sci 1998, 95: 8904-9.
10. Hogg MG, Evans CH, Smith TJ. Leukoregulin induces plasminogen activator inhibitor type-1 in human orbital fibroblasts. Am J Physiol 1995, 269:C359-66.
11. Cao H, Hogg MG, Martino LJ, Smith TJ. Transforming growth factor-β induces plasminogen activator inhibitor type-1 in cultured human orbital fibroblasts. Invest Ophthalmol Vis Sci 1995, 36: 1411-9.
12. Smith TJ, Ahmed A, Hogg MG, Higgins PJ. Interferon gamma is an inducer of plasminogen activator inhibitor type-1 in human orbital fibroblasts. Am J Physiol 1992, 263:C24-9.
13. Smith TJ, Sempowski GD, Wang HS, Del Vecchio PJ, Lippe SD, Phipps RP. Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts. J Clin Endocrinol Metab 1995, 80: 2620-5.
14. Morris RJ, Ritter MA. Association of Thy-1 cell surface differentiation antigen with certain connective tissues in vivo. Cell Tissue Res 1980, 206: 459-75.
15. Smith TJ, Koumas L, Gagnon A, et al. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 2002, 87: 385-92.
16. Sorisky A, Pardasani D, Gagnon A, Smith TJ. Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture. J Clin Endocrinol Metab 1996, 81: 3428-31.
17. Crisp M, Starkey KJ, Lane C, Ham J, Ludgate M. Adipogenesis in thyroid eye disease. Invest Ophthalmol Vis Sci 2000, 41: 3249-55.
18. Starkey K, Heufelder A, Baker G, et al. Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use? J Clin Endocrinol Metab 2003, 88: 55-9.
19. Valyasevi RW, Erickson DZ, Harteneck DA, et al. Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J Clin Endocrinol Metab 1999, 84: 2257-62.
20. Sempowski GD, Rozenblit J, Smith TJ, Phipps RP. Human orbital fibroblasts are activated through CD40 to induce pro-inflammatory cytokine production. Am J Physiol 1998, 274:C707-14.
21. Sciaky D, Brazer W, Center DM, Cruikshank WW, Smith TJ. Cultured human fibroblasts express constitutive IL-16 mRNA: Cytokine induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism. J Immunol 2000, 164: 3806-14.
22. Fries KM, Sempowski GD, Gaspari AA, Blieden T, Looney RJ, Phipp RP. CD 40 expression by human fibroblasts. Clin Immunol Immunopathol 1995, 77: 42-51.
23. Cao HJ, Wang HS, Zhang Y, Ling HY, Phipps RP, Smith TJ. Activation of human orbital fibroblasts thrugh CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression: Insights into potential pathogenic mechanisms of thyroid associated ophthalmopathy. J Biol Chem 1998, 273: 29615-25.
24. Phipps RP, Stein SH, Roper RL. A new view of prostaglandin E regulation of the immune response. Immunol Today 1991, 12: 349-52.
25. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenase)-1 and -2. J Biol Chem 1996, 271: 33157-60.
26. Wang HS, Cao HJ, Winn VD, et al. Leukoregulin induction of prostaglandin endoperoxide H synthase-2 in human orbital fibroblasts: an in vitro model for connective tissue inflammation. J Biol Chem 1996, 271: 22718-28.
27. Cao HJ, Smith TJ. Leukoregulin up-regulation of prostaglandin endoperoxide H synthase-2 expression in orbital fibroblasts. Am J Physiol 1999, 277:C1075-85.
28. 2 synthase expression. J Biol Chem 2002, 277: 16355-64.
29. Smith TJ, Bahn RS, Gorman CA. Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr Rev 1989, 10: 366-91.
30. Spicer AP, Kaback LA, Smith TJ, Seldin MF. Molecular cloning and chracterization of the human and mouse UDP-glucose dehydrogenase genes. J Biol Chem 1998, 273: 25117-24.
31. Kaback LA, Smith TJ. Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1β in human orbital fibroblasts: Potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 1999, 84: 4079-84.
32. Paschke R, Vassart G, Ludgate M. Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathy. Clin Endocrinol (Oxf) 1995, 42: 565-9.
33. Feliciello A, Porcellini A, Ciullo I, Bonavolonta G, Avvedimento EV. Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 1993, 342: 337-8.
34. Wu SL, Yang CSJ, Wang HJ, Liao CL, Chang TJ, Chang TC. Demonstration of thyrotropin receptor mRNA in orbital fat and eye muscle tissues from patients with Graves' ophthalmopathy by in situ hybridization. J Endocrinol Invest 1999, 22: 289-95.
35. Heufelder AE, Dutton CM, Sarkar G, Donovan KA, Bahn RS. Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid 1993, 3: 297-300.
36. Burch HB, Selletti D, Barnes SG, Nagy EV, Bahn RS, Burman KD. Thyrotropin receptor antisera for the detection of immunoreactive protein species in retroocular fibroblasts obtained from patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 1994, 78: 1384-91.
37. Wiersinga WM, Prummel MF. Pathogenesis of Graves' ophthalmopathy-current understanding. J Clin Endocrinol Metab 2001, 86: 501-3.
38. Crisp MS, Lane C, Halliwell M, Wynford-Thomas D, Ludgate M. Thyrotropin receptor transcripts in human adipose tissue. J Clin Endocrinol Metab 1997, 82: 2003-5.
39. Bell A, Gagnon A, Grunder L, Parikh SJ, Smith TJ, Sorisky A. Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts. Am J Physiol 2000, 279:C335-40.
40. Agretti P, Chiovato L, De Marco GD, et al. Real-time PCR provides evidence for thyrotropin receptor mRNA expression in orbital as well as in extraorbital tissues. Eur J Endocrinol 2002 147: 733-9.
41. Rotella CM, Zonefrati R, Toccafondi R, Valente WA, Kohn LD. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J Clin Endocrinol Metab 1986, 62: 357-67.
42. Heufelder AE, Bahn RS. Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts. European J Clin Invest 1992, 22: 529-37.
43. Prichard J, Horst N, Cruikshank W, Smith TJ. Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. J Immunol 2002, 168: 942-50.
44. Weightman DR, Perros P, Sherif IH, Kendall-Taylor P. Autoantibodies to IGF-1 binding sites in thyroid associated ophthalmopathy. Autoimmunity 1993, 16: 251-7.
45. Pritchard J, Horst N, Cruikshank WW, Smith TJ. Immunoglobulin activation of T cell chemoattractants expression in fibroblasts from patients with Graves' disease is mediated through the IGF-1 receptor pathway. J Immunol 2003 170: 6348-54.
46. Smith TJ. Fibroblast biology in thyroid disease. Current Opinion Endocrinol Diabetes. 2002, 9: 393-400.